Impact, in this context, is not a feel-good narrative; it’s a measurable one, even if more qualitatively than quantitatively in some cases. For me, it’s about which healthspan outcome is being targeted, for whom and why? How will progress be measured with replicable methods? What would count as failure? What tradeoffs are acceptable, and which ones are not? When founders and investors are aligned on these questions, capital becomes a tool for building evidence rather than amplifying narrative.
人 民 网 版 权 所 有 ，未 经 书 面 授 权 禁 止 使 用
。搜狗输入法2026对此有专业解读
The iPhone 17e is here: 6 ways Apple just upgraded its cheapest phone
A10-13·特别报道SourcePh" style="display:none"